Category: 3. Business

PagerDuty (PD) shares edged up around 2% today, catching some attention among software investors. While there was no major news announcement, the stock’s modest bump stands out, especially given its recent underperformance this year.

See our latest analysis for PagerDuty.

PagerDuty’s 2% share price lift today brings a small but welcome uptick, considering its 2024 performance has been disappointing, with a year-to-date share price decline of nearly 14% and a 12-month total shareholder return loss of over 22%. While that hints at momentum still struggling to recover, the latest move may reflect shifting sentiment or a growing sense that the risk/reward balance is starting to look more attractive in light of recent results and sector dynamics.

If PagerDuty’s momentum has you rethinking your strategy, it could be the right moment to broaden your perspective and uncover fast growing stocks with high insider ownership

But with shares trading at a notable discount to analyst targets and recent earnings growth outpacing revenue, is PagerDuty now undervalued or is the market already factoring in any turnaround? Could this be an overlooked buying opportunity?

The most popular narrative sees PagerDuty’s fair value at just above $19, compared to a last close of $15.49. This suggests the consensus believes the market is still missing some upside. With the current price notably below projected value, investors are left to weigh whether improving earnings prospects will be realized.

The rapid growth in usage and complexity of digital infrastructure, especially within AI-native and large enterprise customers, along with record platform utilization (over 25% year-over-year growth), points to rising demand for PagerDuty’s core incident management and automation offerings. These trends can drive strong future recurring revenue as digital transformation accelerates globally.

Read the complete narrative.

Want to see why analysts are backing this higher valuation? The secret is a bold earnings turnaround, surging adoption, and a powerful margin shift that underpin the entire narrative. What are the underlying assumptions shaping this outlook? Dig into the details to uncover the full story driving this ambitious price target.

Result: Fair Value of $19.14 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, unexpected customer downgrades or rising competition could quickly weaken the case for a sustained rebound in PagerDuty’s share price.

Find out about the key risks to this PagerDuty narrative.

If you see things differently or want to dig deeper on your own terms, you can craft a personalized take on PagerDuty’s outlook in just minutes. Do it your way

A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding PagerDuty.

If you are eager for other opportunities or want to expand your portfolio, don’t let fresh ideas pass you by. The smartest investors keep looking forward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include PD.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Brookfield Business Partners (NYSE:BBU) stock’s movement over the past month has caught the attention of investors, with shares gaining roughly 26% in the past 3 months despite some recent volatility. Many are weighing the company’s long-term prospects in comparison with shorter-term trends.

See our latest analysis for Brookfield Business Partners.

Brookfield Business Partners has delivered a strong 31% year-to-date share price return. However, recent bouts of volatility brought a sharp pullback this past week. Even with these short-term swings, the company’s one-year total shareholder return of 25% shows momentum is still on its side and suggests confidence in its long-term strategy is building.

If recent market action has sparked your curiosity, now is a great time to broaden your scope and discover fast growing stocks with high insider ownership

With shares trading around $31, about 22% below the average analyst price target, investors must now decide whether Brookfield Business Partners represents an undervalued opportunity or if the market has already priced in future growth expectations.

Brookfield Business Partners is trading at a price-to-sales ratio of only 0.2x, significantly lower than both its closest peers and broader industry benchmarks. With the share price at $31.04, investors are paying less per dollar of revenue than is typical for this sector.

The price-to-sales (P/S) ratio indicates how much investors are willing to pay for each dollar of a company’s sales. For capital goods and industrial businesses, this metric is valuable because it sidesteps profitability issues and focuses on the company’s core revenues, a fundamental driver in industries with fluctuating earnings or in turnarounds.

This deeply discounted multiple suggests that the market is skeptical about Brookfield Business Partners’ ability to convert sales into sustainable profitability, especially since the company is currently unprofitable. However, it also hints at a potential opportunity if the business can execute a turnaround or improve margin performance.

Compared to the global Industrials average of 0.8x and peer group average of 1.2x, Brookfield Business Partners’ P/S ratio stands out as particularly low. This level marks a material discount, which could narrow if the company demonstrates more consistent results or sector sentiment shifts.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Sales of 0.2x (UNDERVALUED)

However, persistent unprofitability and ongoing market skepticism could continue to weigh on the stock. This may limit its upside even if revenues remain strong.

Find out about the key risks to this Brookfield Business Partners narrative.

Looking at Brookfield Business Partners through the lens of our DCF model offers a strikingly different perspective. This method estimates the company is worth significantly more and values the stock at $135.18 compared to its current price of $31.04, suggesting it may be deeply undervalued right now. If both approaches produce such varied results, which story should investors trust?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Brookfield Business Partners for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 874 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

If you want to dig deeper, question these conclusions, or bring your own insights to the table, you can craft a personalized narrative in just a few minutes. Do it your way

A great starting point for your Brookfield Business Partners research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.

Step ahead of the crowd by finding emerging opportunities and smart alternatives on Simply Wall Street’s powerful Screener. Your next winning idea could be just one click away.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BBU.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

• Janux Therapeutics reported its third-quarter 2025 results, posting a net loss of US$24.31 million, an improvement from US$28.06 million a year earlier, while its nine-month net loss grew year-over-year to US$81.68 million.

• Despite continued losses, major analysts reaffirmed positive outlooks after the announcement, signaling ongoing confidence in Janux Therapeutics’ future potential.

• We’ll explore how analyst confidence in the face of widening year-to-date losses shapes the investment narrative for Janux Therapeutics.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 35 best rare earth metal stocks of the very few that mine this essential strategic resource.

Investors considering Janux Therapeutics right now need to believe in the potential for breakthrough innovation in biotechnology, even as the company continues to post sizable net losses and a long path to profitability. The latest quarterly results showed a slightly narrower net loss for the third quarter, but year-to-date losses grew compared to last year, highlighting ongoing spending behind early-stage clinical programs and new product platforms. Despite these financial numbers, leading analysts reiterated positive ratings and substantially higher price targets, which suggests no material shift in sentiment or short-term catalysts as a result of the news. Key events to watch remain progress in clinical trials, any changes in partnership momentum, and the company’s capacity to manage its cash runway as losses accumulate. On the risk side, management turnover and the absence of a clear profitability timeline remain front of mind, especially given the ongoing increase in losses. Yet, the scale of those financial risks is something every shareholder should keep front of mind.

Our valuation report here indicates Janux Therapeutics may be overvalued.

Three retail investors in the Simply Wall St Community provided fair value estimates for Janux ranging from US$48 to US$150 per share. With this broad spectrum of viewpoints, it’s clear that perspectives on Janux’s value are widely split. As you weigh these estimates, remember that clinical progress and the ability to control ongoing losses could make a decisive difference for the company’s future.

Explore 3 other fair value estimates on Janux Therapeutics – why the stock might be worth over 5x more than the current price!

Disagree with this assessment? Create your own narrative in under 3 minutes – extraordinary investment returns rarely come from following the herd.

Opportunities like this don’t last. These are today’s most promising picks. Check them out now:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include JANX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Sana Biotechnology (SANA) caught investor attention after unveiling a focused strategy that prioritizes its SC451 type 1 diabetes and SG293 in vivo CAR T programs. In addition to recent positive clinical results, the company reported a smaller net loss for the quarter, surpassing expectations.

See our latest analysis for Sana Biotechnology.

Sana Biotechnology’s fresh strategic focus and encouraging clinical news have re-energized the stock, with a 147.9% year-to-date share price return making it one of the most eye-catching movers in biotech. Momentum is building as investors warm to the potential of its flagship programs, even though the company’s three-year total shareholder return is still in the red.

If biotech’s rebound has sparked your curiosity, it is a perfect moment to explore breakthrough leaders with our healthcare stocks screener See the full list for free.

But with shares already up nearly 150% this year and analysts forecasting even more upside, the real question is whether Sana Biotechnology is undervalued or if the market has already accounted for its future growth potential.

Sana Biotechnology’s shares trade at a price-to-book (P/B) ratio of 5.6x, making the stock appear expensive compared to its peers and the broader industry benchmarks.

The P/B ratio compares a company’s market price to its book value, giving investors a sense of how much they are paying for each dollar of net assets. In the biotech sector, this metric can sometimes be distorted by heavy R&D spending and a lack of ongoing profits. It still serves as a useful signal when evaluating early-stage or pre-revenue businesses such as SANA.

At 5.6x, SANA trades at more than double the US Biotechs industry average of 2.5x and above the peer average of 4.4x. This reflects a substantial premium, despite Sana Biotechnology being unprofitable and forecast to remain so over the next several years. The market is therefore pricing in significant optimism or hopes for future transformative breakthroughs that are not yet reflected in the company’s current financials.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Book of 5.6x (OVERVALUED)

However, sustained losses and the company’s lack of revenue could challenge optimism if clinical or strategic progress stalls in the coming quarters.

Find out about the key risks to this Sana Biotechnology narrative.

If you see things differently or want to investigate the numbers on your own terms, you can craft your own take in just a few minutes with Do it your way.

A great starting point for your Sana Biotechnology research is our analysis highlighting 1 key reward and 6 important warning signs that could impact your investment decision.

Don’t let opportunity slip by when outstanding stocks are waiting to be uncovered. The right screener can put you ahead of the curve. Take the next step now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SANA.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

This article first appeared on GuruFocus.

Release Date: November 06, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

• Pirelli & C SpA (PLLIF) reported organic revenue growth of 3.7% for the first nine months of 2025, driven by a strong commercial strategy in the high-value segment.

• The company maintained a high profitability margin of 16.1%, outperforming peers and demonstrating effective internal management.

• Pirelli’s technological leadership was reinforced through product innovation, including the development of the Cyberdyne technology, which received recognition for its innovation in smart mobility.

• The company has made significant strides in sustainability, with 100% of electricity for its plants sourced from renewables and a focus on eco-friendly products.

• Pirelli successfully reduced its debt by approximately 280 million year-on-year, showcasing effective financial management and cash generation.

• The macroeconomic environment remains volatile, with challenges such as geopolitical tensions, trade tariffs, and exchange rate fluctuations impacting operations.

• Pirelli faces a negative impact from US tariffs, with an estimated gross impact of 60 million for 2025, despite mitigation efforts.

• The company experienced a decline in standard tire sales, particularly in South America, due to increased competition from Chinese imports.

• Exchange rate depreciation negatively impacted financial results, with a 3.4% adverse effect on revenues.

• The automotive market remains uncertain, with volatility in original equipment demand and disruptions in the supply chain affecting future projections.

Q: How do you see the inventory levels overall and for high-value tires, and do you expect any softening in replacement demand? A: Unidentified_3: The stock levels are quite normalized globally. In Europe, due to the winter season, stock levels are high, which is normal. The market replacement in Q4 is expected to be positive, around 4-5% in high-value replacement, with good performance expected in China and Europe, depending on weather conditions.

Q: Are there plans for further efficiency improvements next year, and what impact do you expect from raw materials in 2026? A: Unidentified_3: We plan to continue our efficiency programs, focusing on automation, digitization, and electrification of factories. We expect a tailwind from raw materials, with an estimated benefit of 30-40 million concentrated in the first half of 2026.

Q: What is your perspective on competition from Asian tire manufacturers, particularly in the high-tech segment? A: Unidentified_3: Chinese tire makers are growing in volume and market share but are not affecting the high-tech segment. The technology gap remains significant, with limited presence in the premium segment. In the high-value segment, Pirelli remains well-protected.

Q: Can you provide insights into the governance situation and whether a stock-funded acquisition is being considered? A: Unidentified_2: No stock-funded acquisition is being considered. The government is negotiating to resolve governance issues, but no extraordinary transactions are on the table.

Q: How do you view the pricing environment in the US, and are there any imbalances in the sector? A: Unidentified_3: We are renegotiating commercial conditions in the US to mitigate duties impact, reviewing terms with carmakers and distributors. We do not perceive any significant imbalance in the sector and are managing challenges effectively.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Black Friday is coming up and you are looking forward to saving some money on Christmas presents. There are lots of offers coming into your inbox so it is difficult to sift through them all but then you see a great bargain from your favourite clothes shop.

You follow the link from the email in the hope of bagging one of the few remaining jumpers you have had your eye on. The website looks identical to the one you have been on many times so you pay your money for the jumper via bank transfer and settle back, content that you have secured a bargain.

The jumper will never arrive, however, as you have fallen for one of the many scams that have caused Black Friday to be called Black Fraud Day by one expert.

This year Black Friday falls on 28 November, but discounts and offers are advertised by some retailers week in advance. The National Cyber Security Centre (NCSC) has warned people to be on their guard in the run up to the day, and to stop the minute a purchase appears suspicious.

The cybersecurity firm Darktrace says there has been a sharp rise in the number of malicious emails mentioning Black Friday through October, with most coming on the last day of the month.

Jonathon Ellison, the director for national resilience at the NCSC, adds: “This is … a time when cyber criminals seek to exploit our increased spending, using trusted brands, popular products, and current events to deceive people into clicking malicious links or sharing personal and financial information.”

The increased availability of artificial intelligence tools means criminals can create authentic-looking websites mimicking famous brands and potentially duping people into handing over money.

They may also create fake small businesses, says Adrian Ludwig of Tools for Humanity, a tech company.

“With AI, fraudsters can now create entire deceptive small-business identities, complete with faces, stories and photo-perfect shops in just minutes,” he says.

What the scam looks like

The offer may come via email or you may see it on social media, posted from an account which was created recently.

The Consumer group Which? says that unrealistically low prices which are inconsistent with other sites should be one of the first alerts.

When you click through you may find a website which is not fully developed. It may not have a privacy policy, a postage address or an “about us” page.

Instead of asking you to pay by credit or debit card, it will request a bank transfer, the preferred method of moving money by organised crime gangs. Website that ask for payment by cryptocurrency should also raise alarm bells.

The illegitimate site may also have an impersonated URL. “Scammers will turn John Lewis into J0hn Lewis (with a zero) … to trick rushed consumers,” said Nathaniel Jones of Darktrace.

There will often be an element of urgency to the sale – the site might say you only have a few minutes to secure the deal, or claim there are only a few items left in stock and that you should act immediately to secure one.

What to do

The NCSC advises anyone who receives an email they suspect is a scam to forward it to the Suspicious Email Reporting Service. Suspicious text messages should be sent to 7726.

If you become a victim of fraud and lose money to a scam, in the UK contact Action Fraud, the national reporting centre for fraud.

But mostly, be alert. If there is anything even remotely suspicious about a sale, stop and think. Try to use a credit card for payments, as in the UK many sales will be protected under the Consumer Credit Act 1974.

It’s been a good week for Deutsche Post AG (ETR:DHL) shareholders, because the company has just released its latest quarterly results, and the shares gained 8.1% to €43.01. Revenues were €20b, approximately in line with whatthe analysts expected, although statutory earnings per share (EPS) crushed expectations, coming in at €0.75, an impressive 24% ahead of estimates. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.

Following last week’s earnings report, Deutsche Post’s 14 analysts are forecasting 2026 revenues to be €85.5b, approximately in line with the last 12 months. Statutory earnings per share are predicted to increase 3.6% to €3.27. Yet prior to the latest earnings, the analysts had been anticipated revenues of €85.8b and earnings per share (EPS) of €3.24 in 2026. The consensus analysts don’t seem to have seen anything in these results that would have changed their view on the business, given there’s been no major change to their estimates.

View our latest analysis for Deutsche Post

There were no changes to revenue or earnings estimates or the price target of €42.81, suggesting that the company has met expectations in its recent result. The consensus price target is just an average of individual analyst targets, so – it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Deutsche Post at €60.00 per share, while the most bearish prices it at €34.00. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It’s pretty clear that there is an expectation that Deutsche Post’s revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 1.4% growth on an annualised basis. This is compared to a historical growth rate of 3.2% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 3.8% annually. So it’s pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Deutsche Post.

The most important thing to take away is that there’s been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it’s tracking in line with expectations. Although our data does suggest that Deutsche Post’s revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year’s earnings. We have estimates – from multiple Deutsche Post analysts – going out to 2027, and you can see them free on our platform here.

However, before you get too enthused, we’ve discovered 1 warning sign for Deutsche Post that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Zalando (XTRA:ZAL) caught the spotlight after revealing strong third-quarter sales growth, fueled by a mix of new business partnerships, the About You acquisition, and its recent five-year deal with the German Football Federation.

See our latest analysis for Zalando.

Following several bold moves, including its About You acquisition and a new CFO announcement, Zalando’s share price response has been turbulent, sliding 30.97% year-to-date despite a burst of trading momentum after Q3 results. Over the longer haul, the 1-year total shareholder return sits at -18.24%, and losses have piled up across three and five years. This hints that while the business is growing on paper, the market remains cautious on a sustained turnaround.

If Zalando’s shifting fortunes make you curious about what else might be on the rise, it could be the perfect moment to broaden your search and discover fast growing stocks with high insider ownership

So, with strong top-line growth but profits under pressure, has Zalando’s recent share price weakness set up an attractive entry point? Or are investors already factoring in all the potential for future gains?

Compared to Zalando’s last close price of €22.24, the most widely followed narrative assigns a much higher fair value. This consensus targets significant upside, capturing optimism surrounding operational changes and strategic growth bets.

The rollout of Zalando’s new AI-powered discovery feed and continued investment in personalized, curated shopping experiences are expected to increase user engagement, shopping frequency, and ultimately drive higher average order value and revenue per customer. This leverages broader consumer migration to mobile/online and personalization.

Read the complete narrative.

How can Zalando climb back? The full narrative teases the secret recipe: ambitious profit margin gains, major earnings leaps, and the kind of aggressive growth usually reserved for digital giants. Don’t miss which financial forecasts and future profit multiples drive this bullish valuation. See what’s powering the premium price target.

Result: Fair Value of €36.85 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, muted consumer demand and intense competition across European markets could easily challenge these bullish growth projections for Zalando in the coming years.

Find out about the key risks to this Zalando narrative.

While analyst fair values point to upside, the current share price is 23.9 times earnings. This tops both the European Specialty Retail sector average of 19.4x and the estimated fair ratio of 22.3x. This suggests investors could be paying a premium for growth that may not materialize quickly. Does the market see something others are missing, or is there risk of a reset?

See what the numbers say about this price — find out in our valuation breakdown.

If the prevailing valuations or strategies do not quite match your own take, dig into the numbers and craft a personalized view. Your unique perspective is just a few clicks away. Do it your way

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Zalando.

Don’t wait for the perfect opportunity to pass you by. Take charge and see how other top picks can add new edge and potential to your strategy using these hand-picked ideas from Simply Wall St.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ZAL.DE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

• Earlier this month, Akamai Technologies announced strong third-quarter results, reporting US$1.05 billion in sales and a significant increase in net income, while also launching the Akamai Inference Cloud, an AI platform developed in partnership with NVIDIA to bring real-time edge AI capabilities closer to end users and devices.

• This rapid commercial adoption and technological advance into AI-powered services highlights a shift in Akamai’s business, positioning the company to address growing demand for distributed edge computing and intelligent security solutions.

• Now, we’ll look at what the launch of Akamai Inference Cloud means for Akamai’s long-term investment narrative and future growth potential.

Find companies with promising cash flow potential yet trading below their fair value.

To own Akamai Technologies shares today, you need to believe that the company’s accelerating pivot to edge-based, AI-powered cloud and security services can offset headwinds in its traditional delivery business and support long-term growth. The launch of Akamai Inference Cloud represents a meaningful short-term catalyst, fueling optimism for near-term revenue acceleration, while customer concentration remains the top risk as revenue realization is still tied closely to a few large contracts. This news does not fundamentally change the importance of landing and scaling key compute and security deals.

Among the latest announcements, Akamai’s launch of the Inference Cloud stands out, as it brings advanced, real-time AI capabilities to the edge and is already attracting production-ready customer interest across sectors like live video, recommendation engines, and smart digital agents. This rapid adoption could reinforce Akamai’s transition away from legacy delivery segments, strengthening the near-term outlook built around cloud infrastructure and security momentum.

However, despite the company’s recent gains, investors should be aware that revenue is still highly dependent on a small number of significant contracts and, if those ramp slower than anticipated…

Read the full narrative on Akamai Technologies (it’s free!)

Akamai Technologies is projected to reach $4.9 billion in revenue and $765.1 million in earnings by 2028. This outlook is based on a 6.1% annual revenue growth rate and reflects an increase in earnings of $340.5 million from the current $424.6 million.

Uncover how Akamai Technologies’ forecasts yield a $95.20 fair value, a 14% upside to its current price.

Simply Wall St Community members estimate Akamai’s fair value from US$66 to US$132, reflecting a broad spectrum of views from five independent analyses. The company’s current growth depends on customers migrating workloads to its new edge and AI platforms, highlighting why opinions about future returns can vary so widely.

Explore 5 other fair value estimates on Akamai Technologies – why the stock might be worth 21% less than the current price!

Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AKAM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Nextracker (NXT) has just unveiled its NX Earth Truss foundation solution for the Australian solar market, supported by a grant from the Australian Renewable Energy Agency. This launch addresses challenging terrain issues that often slow down large-scale solar projects.

See our latest analysis for Nextracker.

Momentum in Nextracker shares has accelerated alongside its innovative Australian launch, with a rapid 26.4% share price return over the past month and an impressive 164.9% year-to-date gain. Investors are clearly responding to both the company’s new technology and the broader enthusiasm for scalable renewable infrastructure. This signals confidence in its growth prospects over both the short and long term.

If news like Nextracker’s expansion has you wondering where future growth will come from, take the opportunity to discover fast growing stocks with high insider ownership

But after such a dramatic run-up, is Nextracker’s current share price an attractive entry point? Or has the market already priced in all the potential upside from its ambitious expansion plans?

The most widely followed narrative places Nextracker’s fair value at $98.65, compared with a recent close of $104.63. This perspective considers both rapid earnings momentum and the sustainability of future returns as the main pieces of its valuation puzzle.

Strategic R&D expansion and partnerships reinforce Nextracker’s leadership in solar technology, positively impacting long-term revenue and growth. Strong demand and localized supply chain enhance competitive advantage, boosting U.S. market share and financial performance.

Read the complete narrative.

Curious how the narrative justifies such a premium? There is a tug-of-war between aggressive growth projections and pressure on profitability. Ready to see which assumption tips the scale?

Result: Fair Value of $98.65 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, ongoing uncertainties around tariffs and heavy reliance on the U.S. market could still challenge Nextracker’s growth trajectory if conditions worsen.

Find out about the key risks to this Nextracker narrative.

Looking through the lens of the market’s most-watched ratio, Nextracker trades at 26.9 times earnings. This is not only below the average for its industry at 29.9x, but also below a peer group average of 38x. Compared to a fair ratio of 34.2x, this signals Nextracker could see re-rating upside if current momentum continues. Does this relative value outweigh any concerns about future growth?

See what the numbers say about this price — find out in our valuation breakdown.

If you want to challenge these conclusions with your own analysis, you can dive in and build a personalized case for Nextracker in just a few minutes. Do it your way

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Nextracker.

Act now and find your edge with Simply Wall Street’s unique tools, which unlock trends, value, and opportunities you might otherwise miss in today’s fast-moving market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NXT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com